Oramed Pharmaceuticals News - ORMP

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 5.18 0.00 0.00 0.00 5.18 06:58:08
more quote information »

Recent News

Date Time Source Heading
12/11/201916:53EDGARInitial Statement of Beneficial Ownership (3)
12/06/201906:02EDGARCurrent Report Filing (8-k)
12/05/201909:12PRNUSOramed Appoints Dr. Arie Mayer to Board of Directors
12/02/201908:25PRNUSOramed to Present a Scientific Poster at International..
11/27/201916:28EDGARAnnual Report (10-k)
11/21/201908:27PRNUSOramed Patent Granted in Japan for Protease Inhibitor, a Key..
11/19/201908:55PRNUSOramed Provides Highlights and Data From Its Phase IIb Oral..
11/14/201907:28PRNUSOramed Pharmaceuticals to Discuss Positive Phase IIb Data at..
11/12/201907:04EDGARCurrent Report Filing (8-k)
11/12/201907:00PRNUSOramed Announces Successful Phase IIb Study of Oral Insulin..
10/23/201916:36EDGARSecurities Registration: Employee Benefit Plan (s-8)
9/18/201908:38PRNUSOramed to Present at Ladenburg Thalmann 2019 Healthcare..
9/17/201908:40PRNUSOramed Announces Last Patient Treated in Pivotal Phase IIb..
9/16/201918:09EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201918:08EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201918:07EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201918:07EDGARInitial Statement of Beneficial Ownership (3)
9/16/201918:07EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201918:06EDGARStatement of Changes in Beneficial Ownership (4)
9/11/201917:18EDGARStatement of Changes in Beneficial Ownership (4)
9/05/201916:49EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/05/201916:42EDGARCurrent Report Filing (8-k)
9/03/201908:25PRNUSOramed to Present at Three Upcoming Conferences
8/21/201917:28EDGARCurrent Report Filing (8-k)
8/06/201913:29EDGARProxy Statement (definitive) (def 14a)
7/29/201906:08EDGARCurrent Report Filing (8-k)
7/19/201912:12EDGARInitial Statement of Beneficial Ownership (3)
7/18/201913:32EDGARStatement of Changes in Beneficial Ownership (4)
7/15/201919:03EDGARStatement of Changes in Beneficial Ownership (4)
7/10/201917:28EDGARQuarterly Report (10-q)
7/10/201908:40PRNUSOramed to Present at World Diabetes Congress
7/02/201908:25PRNUSOramed Announces Xiaoming Gao Joins Board of Directors
7/01/201915:18EDGARCurrent Report Filing (8-k)
6/27/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
6/18/201908:40PRNUSOramed Provides Clinical Update with Meaningful Data..
6/05/201916:24EDGARInitial Statement of Beneficial Ownership (3)
6/03/201909:25PRNUSOramed to Present at BIO International Convention
5/21/201908:55PRNUSOramed Completes Patient Recruitment of Phase IIb HbA1c..
5/16/201917:11EDGARCurrent Report Filing (8-k)
4/29/201908:25PRNUSOramed to Present at ThinkEquity Conference
4/16/201917:03EDGARStatement of Changes in Beneficial Ownership (4)
4/16/201917:02EDGARCurrent Report Filing (8-k)
4/12/201917:08EDGARStatement of Changes in Beneficial Ownership (4)
4/11/201908:55PRNUSOramed to Present at 3rd Annual Clinical Trials Summit
4/10/201917:23EDGARQuarterly Report (10-q)
4/04/201908:55PRNUSOramed Patent Allowed in the U.S. for Oral Exenatide
4/03/201908:55PRNUSOramed to Present at H.C. Wainwright Global Life Sciences..
3/28/201916:58EDGARCurrent Report Filing (8-k)
3/28/201908:40PRNUSOramed Patent Allowed in the U.S. for Key Aspect of Its Oral..
3/26/201908:40PRNUSChinese Regulatory Authority [NMPA] Approves IND Application..
See more news about this stock »
Your Recent History
NASDAQ
ORMP
Oramed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 12:18:59